During the past decade, Atsuchi Neurosurgery Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Atsuchi Neurosurgery Hospital" are "Migraine" (2 trials). Many other conditions were trialed in "Atsuchi Neurosurgery Hospital" in a lesser frequency.

Most popular intervention types in "Atsuchi Neurosurgery Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Rimegepant" (1 trials), "Rimegepant 25 MG" (1 trials) and "Rimegepant 75 MG" (1 trials). Other intervention names were less common.

The vast majority of trials in "Atsuchi Neurosurgery Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Atsuchi Neurosurgery Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Atsuchi Neurosurgery Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Atsuchi Neurosurgery Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".